.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Moodys
Covington
Accenture
Dow
Chubb
Baxter
Cerilliant
Chinese Patent Office

Generated: November 18, 2017

DrugPatentWatch Database Preview

SODIUM PHENYLBUTYRATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium phenylbutyrate and what is the scope of sodium phenylbutyrate patent protection?

Sodium phenylbutyrate
is the generic ingredient in two branded drugs marketed by Alvogen Malta, Par Pharm, Sigmapharm Labs Llc, and Horizon Pharma Inc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred drug master file entries for sodium phenylbutyrate. Four suppliers are listed for this compound.

Pharmacology for SODIUM PHENYLBUTYRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
SODIUM PHENYLBUTYRATE
sodium phenylbutyrate
POWDER;ORAL203918-001Jun 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
SODIUM PHENYLBUTYRATE
sodium phenylbutyrate
TABLET;ORAL204395-001Apr 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
SODIUM PHENYLBUTYRATE
sodium phenylbutyrate
POWDER;ORAL202819-001Mar 22, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
TABLET;ORAL020572-001May 13, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
POWDER;ORAL020573-001Apr 30, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Alvogen Malta
SODIUM PHENYLBUTYRATE
sodium phenylbutyrate
TABLET;ORAL090910-001Nov 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sodium phenylbutyrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
TABLET;ORAL020572-001May 13, 1996► Subscribe► Subscribe
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
POWDER;ORAL020573-001Apr 30, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
McKinsey
Accenture
Cerilliant
AstraZeneca
Mallinckrodt
Fuji
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot